ストックスクリーナーアプリを入手
206.09
1.25%
2.34
前日終値:
$203.75
開ける：
$202.6
24時間の取引高:
387.23K
Relative Volume:
0.33
時価総額：
$29.44B
収益：
$2.31B
当期純損益:
$-208.16M
株価収益率:
-134.12
EPS:
-1.5366
ネットキャッシュフロー:
$76.11M
1週間 パフォーマンス:
-0.70%
1か月 パフォーマンス:
+12.95%
6か月 パフォーマンス:
+7.32%
1年 パフォーマンス:
+34.14%
1日の値動き範囲:
$201.94
$207.79
1週間の範囲:
$192.79
$212.77
52週間の値動き範囲:
$131.81
$256.36
Natera Inc Stock (NTRA) Company Profile
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
206.17 | 29.09B | 2.31B | -208.16M | 76.11M | -1.5366 |
TMO
Thermo Fisher Scientific Inc
|
470.81 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.77 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
572.46 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
116.30 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.75 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | 開始されました | William Blair | Outperform |
| 2026-01-07 | 開始されました | Citigroup | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Natera awarded 30% ongoing royalty in MRD patent litigation - MSN
M&T Bank Corp Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
What Natera (NTRA)'s New Prospera Transplant Data Momentum Means For Shareholders - simplywall.st
Is It Too Late To Consider Natera (NTRA) After Its Strong Multi Year Share Price Run? - Yahoo Finance
Teacher Retirement System of Texas Has $15.06 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Urges High Court To Reject CareDx's False Ad Petition - Law360
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm - TMX Newsfile
Universal Beteiligungs und Servicegesellschaft mbH Has $30.18 Million Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. ($NTRA) CEO and President 2025 Pay Revealed - Quiver Quantitative
[ARS] Natera, Inc. SEC Filing - Stock Titan
Natera (NASDAQ: NTRA) details 2026 meeting agenda, pay votes and equity plan expansion - Stock Titan
Unveiling Natera (NTRA) Q4 outlook: Wall Street estimates for key metrics - MSN
Is It Too Late To Consider Natera (NTRA) After Its Recent Share Price Surge? - simplywall.st
Why (NTRA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Natera (NTRA) Showcases Promising Evidence for Prospera Test at ISHLT Meeting - GuruFocus
17 transplant studies show Prospera flags earlier heart, lung warning signs - Stock Titan
Natera co-founder Sheena Jonathan sells $299,440 in shares By Investing.com - Investing.com India
Natera co-founder Sheena Jonathan sells $299,440 in shares - Investing.com
Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan - Stock Titan
Judge hands Natera 30% ongoing royalty in MRD patent battle - MSN
Natera positioned to capture growing $20 billion MRD opportunity: analyst - MSN
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA) - Yahoo Finance
3 Reasons We’re Fans of Natera (NTRA) - Yahoo Finance
Natera, Inc. $NTRA Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Natera, Inc. (NTRA) Stock Analysis: A 23.78% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Natera Sees RS Rating Improve To 76 - Investor's Business Daily
Court orders 30% ongoing royalty for Natera in patent dispute - MSN
KBC Group NV Buys 14,346 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know - Yahoo Finance
Cwm LLC Has $19 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, UFP Technologies, Mettler-Toledo, and Viatris shares are soaring, what you need to know - MSN
Chicago Capital LLC Purchases 12,805 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Natera (NASDAQ:NTRA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Class Action Certification and CLARITY MRD Data Might Change The Case For Investing In Natera (NTRA) - simplywall.st
NTRA Technical Analysis | Trend, Signals & Chart Patterns | NATERA INC (NASDAQ:NTRA) - ChartMill
NTRA Stock Price, Quote & Chart | NATERA INC (NASDAQ:NTRA) - ChartMill
Natera (NTRA) Tops Q4 Earnings and Revenue Estimates - Eastern Progress
Is It Time To Reassess Natera (NTRA) After Its Mixed Share Price Performance? - simplywall.st
Barclays Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $280 - Moomoo
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates - MSN
Natera, Inc. (NASDAQ:NTRA) Short Interest Up 47.2% in March - MarketBeat
NTRA Initiated Coverage On by William Blair -- Rating Outperform - GuruFocus
NATERA INC : WILLIAM BLAIR INITIATES COVERAGE WITH OUTPERFORM RATING - Moomoo
Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst - Benzinga
Natera Inc stock (US6323071042): Is cell-free DNA testing strong enough to unlock sustained growth? - AD HOC NEWS
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma - BioSpace
William Blair initiates Natera stock with Outperform on growth outlook - Investing.com
William Blair initiates Natera stock with Outperform on growth outlook By Investing.com - Investing.com India
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
Natera Inc (NTRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Apr 06 '26 |
Option Exercise |
9.59 |
58,292 |
559,020 |
2,410,772 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Apr 01 '26 |
Sale |
203.31 |
8,400 |
1,707,814 |
224,885 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Apr 01 '26 |
Sale |
202.30 |
3,000 |
606,899 |
147,882 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Mar 31 '26 |
Option Exercise |
9.59 |
41,708 |
399,980 |
2,352,480 |
1.75%
1.08%
大文字化:
|
ボリューム (24 時間):